Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Boytsov, NN"'
Publikováno v:
Patient Preference and Adherence, Vol 2016, Iss Issue 1, Pp 1205-1215 (2016)
Lulu K Lee,1 Amir Goren,1 Natalie N Boytsov,2 Craig F Donatucci,2 Kevin T McVary3 1Health Outcomes Practice, Kantar Health, New York, NY, 2US Real World Outcomes Research, Eli Lily & Company, Indianapolis, IN, 3Division of Urology, Southern Illinois
Externí odkaz:
https://doaj.org/article/7912205cac0d42b6a8530bf271d85b3e
Autor:
Boytsov, NN, Bhattacharya, R, Saverno, KR, Dixon, L, Abbott, PL, Zhang, X, Larmore, CJ, Datar, M, Gaich, CL, Nair, R
Publikováno v:
In Value in Health May 2018 21 Supplement 1:S201-S202
Autor:
Gorritz M; Real-World Evidence, Health Economics and Outcomes Research, IQVIA Inc, Plymouth Meeting, USA., Boytsov NN; US Medical Division - Autoimmune, Eli Lilly and Company, Indianapolis, USA., Goldblum OM; US Medical Division - Autoimmune, Eli Lilly and Company, Indianapolis, USA., Malatestinic WN; US Medical Division - Autoimmune, Eli Lilly and Company, Indianapolis, USA., Wang X; Real-World Evidence, Health Economics and Outcomes Research, IQVIA Inc, Plymouth Meeting, USA., Wade RL; Real-World Evidence, Health Economics and Outcomes Research, IQVIA Inc, Plymouth Meeting, USA.
Publikováno v:
The Journal of dermatological treatment [J Dermatolog Treat] 2022 Aug; Vol. 33 (5), pp. 2510-2517. Date of Electronic Publication: 2021 Oct 06.
Autor:
Boytsov NN; Eli Lilly and Company, Indianapolis, IN, USA., Gorritz M; IQVIA, Inc., Plymouth Meeting, PA, USA., Wang X; IQVIA, Inc., Plymouth Meeting, PA, USA., Malatestinic WN; Eli Lilly and Company, Indianapolis, IN, USA., Wade RL; IQVIA, Inc., Plymouth Meeting, PA, USA., Goldblum OM; IQVIA, Inc., Plymouth Meeting, PA, USA.
Publikováno v:
The Journal of dermatological treatment [J Dermatolog Treat] 2022 May; Vol. 33 (3), pp. 1707-1717. Date of Electronic Publication: 2021 Mar 23.
Autor:
Wang X; IQVIA, Inc., Plymouth Meeting, PA., Boytsov NN; Eli Lilly and Company, Indianapolis, IN., Gorritz M; IQVIA, Inc., Plymouth Meeting, PA., Malatestinic WN; Eli Lilly and Company, Indianapolis, IN., Goldblum OM; Eli Lilly and Company, Indianapolis, IN., Wade RL; IQVIA, Inc., Plymouth Meeting, PA.
Publikováno v:
Journal of managed care & specialty pharmacy [J Manag Care Spec Pharm] 2022 Jan; Vol. 28 (1), pp. 69-77.
Autor:
Pierce EJ; Lilly Corporate Center, Eli Lilly and Company, 893 Delaware St, Indianapolis, IN, 46285, USA. evangeline.pierce@lilly.com., Boytsov NN; Lilly Corporate Center, Eli Lilly and Company, 893 Delaware St, Indianapolis, IN, 46285, USA., Vasey JJ; Veradigm Health, San Francisco, CA, USA., Sudaria TC; Veradigm Health, San Francisco, CA, USA., Liu X; Lilly Corporate Center, Eli Lilly and Company, 893 Delaware St, Indianapolis, IN, 46285, USA., Lavelle KW; Veradigm Health, San Francisco, CA, USA., Bogdanov AN; Veradigm Health, San Francisco, CA, USA., Goldblum OM; Lilly Corporate Center, Eli Lilly and Company, 893 Delaware St, Indianapolis, IN, 46285, USA.
Publikováno v:
Dermatology and therapy [Dermatol Ther (Heidelb)] 2021 Aug; Vol. 11 (4), pp. 1305-1318. Date of Electronic Publication: 2021 May 30.
Autor:
McGuiness CB; IQVIA, Plymouth Meeting, PA, USA. katy.mcguiness@iqvia.com., Boytsov NN; Eli Lilly and Company, Indianapolis, IN, USA., Zhang X; Eli Lilly and Company, Indianapolis, IN, USA., Wang X; IQVIA, Plymouth Meeting, PA, USA., Kannowski CL; Eli Lilly and Company, Indianapolis, IN, USA., Wade RL; IQVIA, Plymouth Meeting, PA, USA.
Publikováno v:
Rheumatology and therapy [Rheumatol Ther] 2021 Jun; Vol. 8 (2), pp. 793-802. Date of Electronic Publication: 2021 Apr 02.
Autor:
Boytsov NN; 1Eli Lilly, Indianapolis, Indiana., Bhattacharya R; 2Humana Healthcare Research, Louisville, Kentucky., Saverno K; 1Eli Lilly, Indianapolis, Indiana., Dixon L; 3Humana, Louisville, Kentucky., Abbott PL; 3Humana, Louisville, Kentucky., Zhang X; 1Eli Lilly, Indianapolis, Indiana., Gaich CL; 1Eli Lilly, Indianapolis, Indiana., Nair R; 2Humana Healthcare Research, Louisville, Kentucky.
Publikováno v:
Journal of managed care & specialty pharmacy [J Manag Care Spec Pharm] 2019 Aug; Vol. 25 (8), pp. 879-887.
Autor:
Kern DM; HealthCore, Inc, Wilmington, DE, USA., Chang L; Eli Lilly and Company, Indianapolis, IN, USA., Sonawane K; HealthCore, Inc, Wilmington, DE, USA., Larmore CJ; Eli Lilly and Company, Indianapolis, IN, USA., Boytsov NN; Eli Lilly and Company, Indianapolis, IN, USA., Quimbo RA; HealthCore, Inc, Wilmington, DE, USA., Singer J; HealthCore, Inc, Wilmington, DE, USA., Hinton JT; Anthem, Inc, Indianapolis, IN, USA., Wu SJ; HealthCore, Inc, Wilmington, DE, USA., Araujo AB; Eli Lilly and Company, Indianapolis, IN, USA. araujo_andre@lilly.com.
Publikováno v:
Rheumatology and therapy [Rheumatol Ther] 2018 Dec; Vol. 5 (2), pp. 355-369. Date of Electronic Publication: 2018 May 30.
Autor:
Sietsema DL; The CORE Institute, Phoenix, Arizona.; MORE Foundation, Phoenix, Arizona., Araujo AB; Eli Lilly and Company, Indianapolis, Indiana., Wang L; STATinMED Research, Plano, Texas., Boytsov NN; Eli Lilly and Company, Indianapolis, Indiana., Pandya SA; STATinMED Research, Plano, Texas., Haynes VS; Eli Lilly and Company, Indianapolis, Indiana., Faries DE; Eli Lilly and Company, Indianapolis, Indiana., Taylor KA; Eli Lilly and Company, Indianapolis, Indiana., Baser O; Center for Innovation and Outcomes Research, Department of Surgery, Columbia University, New York, NY., Jones CB; The CORE Institute, Phoenix, Arizona.; Orthopaedic Surgery Department, University of Arizona College of Medicine, Phoenix, Arizona.
Publikováno v:
The Journal of bone and joint surgery. American volume [J Bone Joint Surg Am] 2018 Nov 07; Vol. 100 (21), pp. 1819-1828.